Search

Your search keyword '"Eva Jägel-Guedes"' showing total 2 results
Start Over Author "Eva Jägel-Guedes" Publisher sage publishing
2 results on '"Eva Jägel-Guedes"'

1. Cholecalciferol 20 000 IU Once Weekly in HIV-Positive Patients with Low Vitamin D Levels: Result from a Cohort Study

Author

Sebastian Noe MD, Silke Heldwein MD, Rita Pascucchi MD, Celia Oldenbüttel MD, PhD, C. Wiese MD, Ariane von Krosigk MD, Eva Jägel-Guedes MD, Hans Jäger MD, Wolfgang Mayer MD, Christoph D. Spinner MD, and Eva Wolf PhD

Subjects
Diseases of the genitourinary system. Urology, RC870-923
Abstract

Purpose: To evaluate efficacy and safety of 20 000 IU cholecalciferol weekly in HIV-infected patients. Methods: Longitudinal data for 243 HIV-infected patients with paired 25-OH-vitamin D3 values for the same month in 2 consecutive years were stratified by the initiation of supplementation in this retrospective study. Results: After 1 year of administration of cholecalciferol 20 000 IU weekly, about 78% of patients with initial vitamin D level 20 µg/L and 42% achieved levels >30 µg/L. Supplemented patients with baseline vitamin D levels

Published
2017
Full Text
View/download PDF

2. Cholecalciferol 20 000 IU Once Weekly in HIV-Positive Patients with Low Vitamin D Levels: Result from a Cohort Study

Author

Christoph D. Spinner, Silke Heldwein, Celia Oldenbüttel, Carmen Wiese, Hans Jäger, Eva Wolf, Eva Jägel-Guedes, Sebastian Noe, Ariane von Krosigk, Wolfgang Mayer, and Rita Pascucchi

Subjects
Adult, Male, medicine.medical_specialty, Immunology, Human immunodeficiency virus (HIV), Once weekly, 030209 endocrinology & metabolism, Dermatology, medicine.disease_cause, lcsh:RC870-923, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, HIV Seropositivity, Vitamin D and neurology, medicine, Humans, 030212 general & internal medicine, Longitudinal Studies, Vitamin D, Cholecalciferol, Retrospective Studies, Hypocalcemia, business.industry, Absolute risk reduction, Retrospective cohort study, Vitamins, Middle Aged, Alkaline Phosphatase, Vitamin D Deficiency, lcsh:Diseases of the genitourinary system. Urology, Infectious Diseases, chemistry, Alkaline phosphatase, Calcium, Female, business, Cohort study
Abstract

Purpose: To evaluate efficacy and safety of 20 000 IU cholecalciferol weekly in HIV-infected patients. Methods: Longitudinal data for 243 HIV-infected patients with paired 25-OH-vitamin D3 values for the same month in 2 consecutive years were stratified by the initiation of supplementation in this retrospective study. Results: After 1 year of administration of cholecalciferol 20 000 IU weekly, about 78% of patients with initial vitamin D level 20 µg/L and 42% achieved levels >30 µg/L. Supplemented patients with baseline vitamin D levels Conclusion: The dose of 20 000 IU of cholecalciferol once weekly was found to be safe and effective. Normalization of vitamin D levels within 1 year was observed in 42% to 75% of the patients.

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results